Serenex.

PositionTRIANGLE

DURHAM -- Serenex, a drug-discovery company, raised $30 million in third-round venture capital. Investors were led by Geneva, Ill.-based Ritchie Capital Management. The company, which is working on a treatment for the side effects of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT